IPAD-DB ID | C00149 |
Name | Oxyresveratrol (9) |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 4 H 1 2 O 4 |
Molecular Weight | 244.24g/mol |
IUPAC Name | 4-[(E)-2-(3, 5-dihydroxyphenyl)ethenyl]benzene-1, 3-diol |
InChI | InChI=1S/C14H12O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h1-8, 15-18H/b2-1+ |
InChIKey | PDHAOJSHSJQANO-OWOJBTEDSA-N |
Canonical SMILES | C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O |
PubChem CID | 5281717 |
DrugBank Accession Number | - |
CAS Registry Number | 29700-22-9 |
Molecular Weight(Computed by SwissADME) | 244.24 |
Hac(Computed by SwissADME) | 18 |
Volume(Computed by ADMETlab 2.0) | 250.293 |
Density(Computed by ADMETlab 2.0) | 0.975 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 13 |
Flexibility(Computed by ADMETlab 2.0) | 0.154 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.181 |
LogD(Computed by ADMETlab 2.0) | 3.156 |
logP(Computed by ADMETlab 2.0) | 2.68 |
TPSA(Computed by SwissADME) | 80.92 Ų |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.45 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |